LISA KHALIL: Open Payments
NPI 1194189324 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 32 payments from 15 companies in 2025. Trend: 2023 $363 · 2024 $590 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $237 |
| Novo Nordisk Inc | 5 | $92 |
| Amgen Inc. | 2 | $65 |
| Boston Scientific Corporation | 1 | $58 |
| Abbott Laboratories | 2 | $58 |
| ABBVIE INC. | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $19 |
Products named: AIRSUPRA, BREZTRI, Ozempic, WATCHMAN FLX, FREESTYLE LIBRE 3, REPATHA, AUSTEDO XR, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
